The San Antonio Breast Cancer Symposium (SABCS) and the American Association for Cancer Research (AACR), will honor Dr. Celina Kleer with the 2019 AACR Outstanding Investigator Award for Breast Cancer Research, supported by the Breast Cancer Research Foundation (BCRF), during the 2019 SABCS, to be held Dec. 10-14 at the Henry B. González Convention Center, San Antonio.
Dr. Kleer, the Harold A. Oberman collegiate professor of pathology at the University of Michigan Medical School and Rogel Cancer Center, is being recognized for her work in generating key insights into the development of aggressive forms of breast cancer and for advancing the characterization of clinical biomarkers and potential therapeutic targets for these cancer subsets. Specifically, her groundbreaking research led to both the initial demonstration of EZH2 overexpression in metastatic hormone receptor negative breast cancer and the elucidation of molecular determinants of metaplastic breast carcinoma. Kleer will present a lecture on Friday, Dec. 13, at 11:30 a.m. titled, “Novel non-canonical functions of EZH2 in triple negative breast cancer.”
Dr. Kleer will receive the 2020 ASIP Outstanding Investigator Award during the ASIP Annual Meeting at Experimental Biology 2020 in San Diego (April 4-7, 2020).